182 related articles for article (PubMed ID: 22205345)
21. Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood.
Perez-Roca L; Adame-Castillo C; Campdelacreu J; Ispierto L; Vilas D; Rene R; Alvarez R; Gascon-Bayarri J; Serrano-Munoz MA; Ariza A; Beyer K
Aging Dis; 2018 Apr; 9(2):208-219. PubMed ID: 29896411
[TBL] [Abstract][Full Text] [Related]
22. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathology of Lewy body diseases.
Beyer K; Domingo-Sàbat M; Ariza A
Int J Mol Sci; 2009 Mar; 10(3):724-45. PubMed ID: 19399218
[TBL] [Abstract][Full Text] [Related]
24. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
[TBL] [Abstract][Full Text] [Related]
25. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
[TBL] [Abstract][Full Text] [Related]
27. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
Dalfó E; Ferrer I
Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629
[TBL] [Abstract][Full Text] [Related]
28. HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson's Disease and Dementia with Lewy Bodies.
Bohush A; Niewiadomska G; Weis S; Filipek A
J Parkinsons Dis; 2019; 9(1):97-107. PubMed ID: 30741686
[TBL] [Abstract][Full Text] [Related]
29. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
30. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
[TBL] [Abstract][Full Text] [Related]
31. Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.
Feleke R; Reynolds RH; Smith AM; Tilley B; Taliun SAG; Hardy J; Matthews PM; Gentleman S; Owen DR; Johnson MR; Srivastava PK; Ryten M
Acta Neuropathol; 2021 Sep; 142(3):449-474. PubMed ID: 34309761
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
Paleologou KE; Oueslati A; Shakked G; Rospigliosi CC; Kim HY; Lamberto GR; Fernandez CO; Schmid A; Chegini F; Gai WP; Chiappe D; Moniatte M; Schneider BL; Aebischer P; Eliezer D; Zweckstetter M; Masliah E; Lashuel HA
J Neurosci; 2010 Mar; 30(9):3184-98. PubMed ID: 20203178
[TBL] [Abstract][Full Text] [Related]
33. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
[TBL] [Abstract][Full Text] [Related]
34. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
35. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
Francis PT
J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
[TBL] [Abstract][Full Text] [Related]
36. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
Kasanuki K; Iseki E; Kondo D; Fujishiro H; Minegishi M; Sato K; Katsuse O; Hino H; Kosaka K; Arai H
Neurosci Lett; 2014 May; 569():68-73. PubMed ID: 24704327
[TBL] [Abstract][Full Text] [Related]
37. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
[TBL] [Abstract][Full Text] [Related]
38. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
39. Synphilin-1-binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease.
Tanji K; Mori F; Kito K; Kakita A; Mimura J; Itoh K; Takahashi H; Kamitani T; Wakabayashi K
J Neuropathol Exp Neurol; 2011 Oct; 70(10):879-89. PubMed ID: 21937912
[TBL] [Abstract][Full Text] [Related]
40. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
